Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Richeldi, B. M. Bergamini, M. Losi, K. Ewer, F. Balli, L. M. Fabbri, A. Lalvani (Modena, Italy; Oxford, United Kingdom). Early detection and monitoring of progressive neonatal multidrug-resistant M. tuberculosis infection by T cell-based assay. Eur Respir J 2004; 24: Suppl. 48, 1317

Member's Comments

No comment yet.

Related content which might interest you: Improved tracking of nosocomial transmission of multidrug resistant M. tuberculosis with a novel T cell-based test Source: Eur Respir J 2003; 22: Suppl. 45, 167s Year: 2003 Evaluation of a rapid bactriophage assay for the detection of mycobacterium tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Comparison of two in vitro IFN-γ assays for detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Colorimetric assays for rapid drug susceptibility testing of Mycobacterium tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 167s Year: 2003 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test Source: Eur Respir J 2006; 28: 16-23 Year: 2006 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Our experience of T cell assays in the diagnosis of MTB disease and latent infection Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 FluoroType MTB system for the detection of pulmonary tuberculosis Source: ERJ Open Res, 3 (2) 00113-2016; 10.1183/23120541.00113-2016 Year: 2017 Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum Source: Eur Respir J 2014; 44: 254-257 Year: 2014 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010 Persistent M. tuberculosis infection: experimental model of endogenously re-activated TB Source: Eur Respir J 2002; 20: Suppl. 38, 582s Year: 2002 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 Early diagnosis of sub-clinical multidrug-resistant tuberculosis Source: Annual Congress 2003 - The various appearance of resistance Year: 2003 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006